Open | - |
Close | - |
Volume / Avg. | 0 / 153.077K |
Day Range | - - - |
52 Wk Range | 2.750 - 6.450 |
Market Cap | $124.090M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 3% |
Days to Cover | 4.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Anixa Biosciences (NASDAQ: ANIX) through any online brokerage.
Other companies in Anixa Biosciences’s space includes: Vincerx Pharma (NASDAQ:VINC), Outlook Therapeutics (NASDAQ:OTLK), Barinthus Biotherapeutics (NASDAQ:BRNS), Vistagen Therapeutics (NASDAQ:VTGN) and Emergent BioSolutions (NYSE:EBS).
The latest price target for Anixa Biosciences (NASDAQ: ANIX) was reported by HC Wainwright & Co. on Tuesday, February 13, 2024. The analyst firm set a price target for 12.00 expecting ANIX to rise to within 12 months (a possible 208.48% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Anixa Biosciences (NASDAQ: ANIX) is $3.89 last updated March 18, 2024 at 9:19 AM EDT.
There are no upcoming dividends for Anixa Biosciences.
Anixa Biosciences’s Q2 earnings are confirmed for Wednesday, June 12, 2024.
There is no upcoming split for Anixa Biosciences.
Anixa Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.